Daré Bioscience, Inc. (DARE)
0.8428
-0.01
(-0.96%)
USD |
NASDAQ |
Oct 02, 16:00
0.8353
-0.01
(-0.89%)
After-Hours: 20:00
Daré Bioscience Max Drawdown (5Y) : 97.24% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 97.24% |
| August 31, 2026 | 97.12% |
| July 31, 2026 | 95.72% |
| June 30, 2026 | 95.72% |
| May 31, 2026 | 96.17% |
| April 30, 2026 | 96.36% |
| March 31, 2026 | 96.74% |
| February 28, 2026 | 96.74% |
| January 31, 2026 | 96.74% |
| December 31, 2025 | 96.77% |
| November 30, 2025 | 97.21% |
| October 31, 2025 | 97.59% |
| September 30, 2025 | 97.62% |
| August 31, 2025 | 98.00% |
| July 31, 2025 | 98.00% |
| June 30, 2025 | 98.06% |
| May 31, 2025 | 98.06% |
| April 30, 2025 | 98.40% |
| March 31, 2025 | 98.75% |
| February 28, 2025 | 99.21% |
| January 31, 2025 | 99.21% |
| December 31, 2024 | 99.23% |
| November 30, 2024 | 99.25% |
| October 31, 2024 | 99.30% |
| September 30, 2024 | 99.33% |
| Date | Value |
|---|---|
| August 31, 2024 | 99.33% |
| July 31, 2024 | 99.33% |
| June 30, 2024 | 99.33% |
| May 31, 2024 | 99.33% |
| April 30, 2024 | 99.33% |
| March 31, 2024 | 99.33% |
| February 29, 2024 | 99.33% |
| January 31, 2024 | 99.33% |
| December 31, 2023 | 99.33% |
| November 30, 2023 | 99.41% |
| October 31, 2023 | 99.41% |
| September 30, 2023 | 99.41% |
| August 31, 2023 | 99.41% |
| July 31, 2023 | 99.41% |
| June 30, 2023 | 99.41% |
| May 31, 2023 | 99.41% |
| April 30, 2023 | 99.41% |
| March 31, 2023 | 99.41% |
| February 28, 2023 | 99.41% |
| January 31, 2023 | 99.41% |
| December 31, 2022 | 99.41% |
| November 30, 2022 | 99.41% |
| October 31, 2022 | 99.41% |
| September 30, 2022 | 99.41% |
| August 31, 2022 | 99.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Elite Pharmaceuticals, Inc. | 87.92% |
| Eton Pharmaceuticals, Inc. | 79.94% |
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
| Veru, Inc. | 99.12% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -60.73 |
| Beta (5Y) | 1.013 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 70.69% |
| Historical Sharpe Ratio (5Y) | -0.7157 |
| Historical Sortino (5Y) | -1.261 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.48% |